Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: January 2023

1/13/2023 Import of Veterinary Drug and Feed Supplements to Russia (November 2022)

From January to November 2022, Russia imported 34 billion rubles’ worth of veterinary drugs (customs clearance and VAT included; import from EEU countries excluded), up 2% from the same period in 2021. In physical terms, the import grew 5.1%, with 30.6 million packages. As for feed supplements, the import fell 6.5%, with 37 billion rubles. In physical terms, the import, 133,900 tons, went down 11.3% from January–November 2021.

1/10/2023 Pharmaceutical Drug Import to Russia (November 2022)

In January–November 2022, Russia imported 758.5 billion rubles’ worth of ready-made pharmaceutical drugs (customs clearance and VAT included), up 8% from the same period in 2021. As for bulk drugs, the import was 167.9 billion rubles, up 11.6%. In physical terms, the import of both groups is unlikely to start growing again—ready-made drugs went down 8.8%, with 1.51 billion packages imported, and bulk drugs went down 28.6%, with 1.38 billion minimum dosage units (MDU).